Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Biomarkers for Early and Accurate Diagnosis of Alzheimer's Disease in Primary Care

NCT07401849 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT07401849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07401849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Biomarkers for Early and Accurate Diagnosis of Alzheimer's Disease in Primary Care
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
November 30, 2026
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, biomarker in early diagnosis, biomarkers / blood, mild cognitive impairment (mci)